Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (2993)	1/4/2008 3:00:49 AM
From: Icebrg	of 3044

Millennium Pharmaceuticals "outperform" Thursday, January 03, 2008 7:13:55 AM ET Robert W. Baird NEW YORK, January 3 (newratings.com) - Analysts at Robert W Baird reiterate their "outperform" rating on Millennium Pharmaceuticals Inc (MLNM.NAS). The target price is set to $18. In a research note published this morning, the analysts mention that the Velcade revenue estimates for 4Q07 and 2008 have been raised marginally to $75 million and $325 million, respectively. While the robust Wolters-Kluwer Health prescription data for October and November suggests Velcade revenues of about $80 million in 4Q07, this data has not been completely reliable, the analysts say. Millennium Pharmaceuticals may provide conservative and wide-ranging guidance for FY08 Velcade revenues, Robert W Baird adds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next